Your browser doesn't support javascript.
What can we learn from Israel's rapid roll out of COVID 19 vaccination?
McKee, Martin; Rajan, Selina.
  • McKee M; Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, 15-17 Tavistock Place, London, WC1H 9SH, UK. martin.mckee@lshtm.ac.uk.
  • Rajan S; Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, 15-17 Tavistock Place, London, WC1H 9SH, UK.
Isr J Health Policy Res ; 10(1): 5, 2021 01 26.
Article in English | MEDLINE | ID: covidwho-1050471
ABSTRACT
Israel has led the world in rolling out its COVID-19 vaccination program. This experience provides lessons that others can learn from. It is, however, necessary to consider some national specificities, including the small size of the country, its young population, and the political imperative to drive this program forward. Israel also has a number of other advantages, including a strong public health infrastructure. The lessons that can be learnt include the importance of coordinating delivery mechanisms with the inevitable prioritisation of groups within the population, timely deployment of a skilled cadre of health workers, a recognition that not everyone in the population shares in the benefits of digital connectedness, the need to reach out to disadvantaged groups, based on an understanding of the barriers that they face, and the importance of placing COVID-19 vaccination within a comprehensive response to the pandemic.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Randomized controlled trials Topics: Vaccines Limits: Humans Country/Region as subject: Asia Language: English Journal: Isr J Health Policy Res Year: 2021 Document Type: Article Affiliation country: S13584-021-00441-5

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Randomized controlled trials Topics: Vaccines Limits: Humans Country/Region as subject: Asia Language: English Journal: Isr J Health Policy Res Year: 2021 Document Type: Article Affiliation country: S13584-021-00441-5